| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8528424 | Clinical Therapeutics | 2017 | 12 Pages | 
Abstract
												We found no differences in patient characteristics between patients with and without LDL-C measurements after being newly diagnosed with CAD. Performance and frequency of LDL-C measurements were clearly associated with better, higher frequency of intensification of statin medication, lower achieved LDL-C levels, and a higher proportion of patients achieving the LDL-C goal of <70 mg/dL. These results suggest an important role of LDL-C measurements for secondary prevention after the initial diagnosis of CAD.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Medicine and Dentistry (General)
												
											Authors
												Christoph MD, Moritz MD, Nils Staebe, Julian MD, Rebecca Kohsiack, Francisco PhD, Niklas MD, Mahir MD, Tanja PhD, Christoph MD, Benedikt MD, Dirk MD, Karsten MD, Stefan MD, Fabian J. MD, Renate B. MD, MSc, 
											